Reduction of Antibiotic Resistance Genes in Intestinal Microbiota of Patients With Recurrent Clostridium difficile Infection After Fecal Microbiota Transplantation

Clinical Infectious Diseases

Volumn 63, Issue 5, 2016, Pages 710-711

  Jouhten, Hanne ^a   Mattila, Eero ^b   Arkkila, Perttu ^b   Satokari, Reetta ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; LINCOSAMIDE; MACROLIDE; MULTIDRUG RESISTANCE PROTEIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN DERIVATIVE; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC RESISTANCE GENE; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE INFECTION; EGGERTHELLA; FECAL MICROBIOTA TRANSPLANTATION; GENE; HUMAN; INTESTINE FLORA; LETTER; METAGENOMICS; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION; RUMINOCOCCUS; VANB GENE; CLOSTRIDIUM INFECTION; FECES; MICROFLORA; PEPTOCLOSTRIDIUM DIFFICILE;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DRUG RESISTANCE, MICROBIAL; FECAL MICROBIOTA TRANSPLANTATION; FECES; GASTROINTESTINAL MICROBIOME; HUMANS; MICROBIOTA;

EID: 84995483968     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw390     Document Type: Letter

References (10)

1. Millan B, Park H, Hotte N, et al. Fecal microbial transplants reduce antibiotic-resistant genes in patients with recurrent Clostridium difficile infection. Clin Infect Dis 2016; 62:1479-86.
2. Satokari R, Mattila E, Kainulainen V, Arkkila PE. Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection-an observational cohort study. Aliment Pharmacol Ther 2015; 41:46-53.
3. Mattila E, Uusitalo-Seppälä R, Wuorela M, et al. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 2012; 142:490-6.
4. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368:407-15.
5. Fuentes S, van Nood E, Tims S, et al. Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection. ISME J 2014; 8:1621-33.
6. Ballard SA, Pertile KK, Lim M, Johnson PD, Grayson ML. Molecular characterization of vanB elements in naturally occurring gut anaerobes. Antimicrob Agents Chemother 2005; 49:1688-94.
7. Guerreiro J, Monteiro V, Ramos C, et al. Lactobacillus pentosus B231 isolated from a Portuguese PDO cheese: production and partial characterization of its bacteriocin. Probiotics Antimicrob Proteins 2014; 6:95-104.
8. Stinear TP, Olden DC, Johnson PD, Davies JK, Grayson ML. Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. Lancet 2001; 357:855-6.
9. Graham M, Ballard SA, Grabsch EA, Johnson PD, Grayson ML. High rates of fecal carriage of nonenterococcal vanB in both children and adults. Antimicrob Agents Chemother 2008; 52:1195-7.
10. Li SS, Zhu A, Benes V, et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 2016; 352:586-9.